drugset / Trial / NCT02702505

Success and Color Stability of MTA Pulpotomized Primary Molars: an RCT

NCT02702505

RandomizedParallel-groupOpen-labelTreatment

Summary

Mineral trioxide aggregate has been previously FDA approved as an endodontic filler. Its use in vital teeth has demonstrated significant color change post-treatment leaving it ineffective for esthetic use.. The new formulation will be tested to see if has the same effect.

Timeline

Start
2014-11
Primary completion
2017-12
Completion
2017-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject NeoMTA Unknown

Indications